Among major news this week, Dynavax Technologies DVAX finally gained FDA approval for its hepatitis ... Achillion's HCV Partnership with J&J Terminated, Stock Falls). Year to date, Achillion’s shares are down 10.7% compared to the …
The stock has more than doubled in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DVAX
more than 10 times the stock’s daily average volume of around 220,000. The company had no specific news today. Dynavax Technologies Corp. (NASDAQ: DVAX) dropped by about 4.8% on Wednesday to post a new 52-week low at …
DVAX closed Thursday's trading at $20.05, down 3.84%. In after-hours, the stock was up 15.46% to $23.10. Omeros Corp. (OMER) has reported strong results for the third quarter ended September 30, 2017, lifting investors' spirits. Net loss for …
Dynavax Technologies Corporation (DVAX) rose 75 cents to close at $23.95 on relatively light volume of 1.9 million shares traded Wednesday. The stock on Monday broke out of a 3-week consolidation on news that the company is evaluating …
--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DVAX at https://www.zacks.com/ap/DVAX Keywords: Dynavax …